# Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi

> **NCT01326754** · NA · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 498 (actual)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** Artemether-lumefantrine combination
- **DRUG:** Artesunate-amodiaquine combination
- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT01326754
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 498 (ACTUAL)
- **Last updated:** 2013-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326754, "Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01326754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*